Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy. A team of researchers led by Rudolf Valenta from MedUni Vienna’s Center for Pathophysiology, Infectiology and Immunology has now demonstrated that a protein contained in the BM32 vaccine against grass pollen allergy induces antibodies that prevent the hepatitis […]
Read More… from Chronic hepatitis B: vaccine against grass pollen allergy potential treatment
The personal story of the journey of a young adult with hepatitis B infection brings new insights into the challenges that can be encountered, and about the way that stigma can be a barrier to high quality care. “As a young girl in East Africa, I was the primary caregiver to my mother who lived […]
Organ-on-chip technology has entered a new level as scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs. Artificial human organs, or organ-on-chip technology, simulate a whole organ’s cell make up and physiology. They act as alternatives to animal models in drug safety testing, […]
Read More… from How pathogens interact with organ-on-chip technology
On World Hepatitis Day, Dr Philippa Matthews, a Wellcome Trust Clinical Research Fellow, puts the spotlight on neglected viruses including hepatitis B and hepatitis C. Some infections are good headline-grabbers – and alongside headlines, come education, engagement, investment, advocacy and action. On the global stage, these diseases include malaria, tuberculosis and HIV, and at home […]